miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2

Carcinogenesis

Volumn 35, Issue 2, 2014, Pages 292-301

  Zhang, Hai Feng ^a,b   Zhang, Kai ^c   Liao, Lian Di ^a   Li, Li Yan ^a   Du, Ze Peng ^a   Wu, Bing Li ^a   Wu, Jian Yi ^a   Xu, Xiu E ^a   Zeng, Fa Min ^a   Chen, Bo ^a   Cao, Hui Hui ^a   Zhu, Meng Xiao ^a   Dai, Li Hua ^a   Long, Lin ^a   Wu, Zhi Yong ^d   Lai, Raymond ^b   Xu, Li Yan ^a   Li, En Min ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NANKAI UNIVERSITY   (China)

^d SHANTOU CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; KINDLIN 2 PROTEIN; MICRORNA 200B; PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ARTICLE; BIOLOGICAL ACTIVITY; CANCER INHIBITION; CANCER STAGING; CANCER SURVIVAL; CARCINOMA CELL; CELL SPREADING; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FOCAL ADHESION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION;

CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CYTOSKELETON; ESOPHAGEAL NEOPLASMS; FEMALE; FOCAL ADHESIONS; HUMANS; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MICRORNAS; MIDDLE AGED; MUTAGENESIS, SITE-DIRECTED; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PHOSPHORYLATION; PROGNOSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 84893345046     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt320     Document Type: Article

References (51)

1. Parkin,D.M. et al. (2005) Global cancer statistics, 2002. Cancer J. Clin., 55, 74-108.
2. Enzinger,P.C. et al. (2003) Esophageal cancer. N. Engl. J. Med., 349, 2241-2252.
3. McCann,J. (1999) Esophageal cancers: changing character, increasing incidence. J. Natl Cancer Inst., 91, 497-498.
4. Ries,L.A. et al. (2002) SEER Cancer Statistics Review, 1973-1999. National Cancer Institute, Bethesda, MD.
5. Kimura,H. et al. (1999) Number of lymph node metastases influences survival in patients with thoracic esophageal carcinoma: therapeutic value of radiation treatment for recurrence. Dis. Esophagus, 12, 205-208.
6. Valastyan,S. et al. (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell, 137, 1032-1046.
7. Korpal,M. et al. (2011) Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat. Med., 17, 1101-1108.
8. Zhang,L. et al. (2013) Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis, 34, 577-586.
9. Valastyan,S. et al. (2011) Roles for microRNAs in the regulation of cell adhesion molecules. J. Cell Sci., 124(Pt 7), 999-1006.
10. Bracken,C.P. et al. (2008) A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res., 68, 7846-7854.
11. Korpal,M. et al. (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem., 283, 14910-14914.
12. Park,S.M. et al. (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev., 22, 894-907.
13. Burk,U. et al. (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep., 9, 582-589.
14. Gibbons,D.L. et al. (2009) Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev., 23, 2140-2151.
15. Wu,B.L. et al. (2011) MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World J. Gastroenterol., 17, 79-88.
16. Hamano,R. et al. (2011) Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin. Cancer Res., 17, 3029-3038.
17. Fang,W.K. et al. (2010) Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor. Hum. Pathol., 41, 1456-1465.
18. Camp,R.L. et al. (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res., 10, 7252-7259.
19. Selbach,M. et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature, 455, 58-63.
20. Elson-Schwab,I. et al. (2010) MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One, 5, e13176.
21. Cochrane,D.R. et al. (2009) MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol. Cancer Ther., 8, 1055-1066.
22. Bimpaki,E.I. et al. (2010) MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis. Clin. Endocrinol. (Oxf)., 72, 744-751.
23. An,Z. et al. (2010) Kindlin-2 is expressed in malignant mesothelioma and is required for tumor cell adhesion and migration. Int. J. Cancer, 127, 1999-2008.
24. Yu,Y. et al. (2012) Kindlin 2 forms a transcriptional complex with ß-catenin and TCF4 to enhance Wnt signalling. EMBO Rep., 13, 750-758.
25. Shapiro,G.I. (2006) Cyclin-dependent kinase pathways as targets for cancer treatment. J. Clin. Oncol., 24, 1770-1783.
26. Gueron,G. et al. (2009) Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol. Cancer Res., 7, 1745-1755.
27. Yu,P. et al. (2001) p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene, 20, 484-489.
28. Li,T. et al. (2011) P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformation. Carcinogenesis, 32, 659-666.
29. Bodemann,B.O. et al. (2008) Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat. Rev. Cancer, 8, 133-140.
30. Valderrama,F. et al. (2012) Radixin regulates cell migration and cell-cell adhesion through Rac1. J. Cell Sci., 125(Pt 14), 3310-3319.
31. Tu,Y. et al. (2003) Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation. Cell, 113, 37-47.
32. He,Y. et al. (2011) Role of kindlin-2 in fibroblast functions: implications for wound healing. J. Invest. Dermatol., 131, 245-256.
33. Bandyopadhyay,A. et al. (2012) Functional differences between kindlin-1 and kindlin-2 in keratinocytes. J. Cell Sci., 125(Pt 9), 2172-2184.
34. Mooney,D.J. et al. (1995) Cytoskeletal filament assembly and the control of cell spreading and function by extracellular matrix. J. Cell Sci., 108(Pt 6), 2311-2320.
35. Small,J.V. et al. (2005) The comings and goings of actin: coupling protrusion and retraction in cell motility. Curr. Opin. Cell Biol., 17, 517-523.
36. Mattila,P.K. et al. (2008) Filopodia: molecular architecture and cellular functions. Nat. Rev. Mol. Cell Biol., 9, 446-454.
37. Hall,A. (1998) Rho GTPases and the actin cytoskeleton. Science, 279, 509-514.
38. Webb,D.J. et al. (2003) Illuminating adhesion complexes in migrating cells: moving toward a bright future. Curr. Opin. Cell Biol., 15, 614-620.
39. Mitra,S.K. et al. (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol., 18, 516-523.
40. Schlaepfer,D.D. et al. (1999) Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol., 71, 435-478.
41. Zhang,X. et al. (2008) Talin depletion reveals independence of initial cell spreading from integrin activation and traction. Nat. Cell Biol., 10, 1062-1068.
42. Shimono,Y. et al. (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell, 138, 592-603.
43. Wellner,U. et al. (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol., 11, 1487-1495.
44. Iliopoulos,D. et al. (2010) Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol. Cell, 39, 761-772.
45. Schliekelman,M.J. et al. (2011) Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res., 71, 7670-7682.
46. Qin,Y.R. et al. (2008) Comparative genomic hybridization analysis of genetic aberrations associated with development of esophageal squamous cell carcinoma in Henan, China. World J. Gastroenterol., 14, 1828-1835.
47. Carneiro,A. et al. (2008) Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer. BMC Cancer, 8, 98.
48. Karaköse,E. et al. (2010) The kindlins at a glance. J. Cell Sci., 123(Pt 14), 2353-2356.
49. Yu,Y. et al. (2013) Kindlin 2 promotes breast cancer invasion via epigenetic silencing of the microRNA200 gene family. Int. J. Cancer, 133, 1368-1379. doi:10.1002/ijc.28151.
50. Yamaguchi,H. et al. (2007) Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim. Biophys. Acta, 1773, 642-652.
51. Sossey-Alaoui,K. et al. (2009) The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion. J. Biol. Chem., 284, 33019-33029.